MGRNOX-guided general anesthesia to reduce opioid use during laparoscopic gallbladder surgery
Official title: Effect of MGRNOX-Guided General Anesthesia on Opioid Consumption in Patients:A Randomized Controlled Trial
Run by Peking University Shenzhen Hospital · NCT07004686 · Data updated 2026-11-12
This trial will see if using the EEG-based MGRNOX index to guide anesthesia can reduce opioid use during laparoscopic cholecystectomy in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 112 (estimated) |
| Sponsor | Peking University Shenzhen Hospital Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Status | Recruiting |
| Started | June 28, 2025 |
| Main results expected | May 30, 2026 |
| Study ends | May 30, 2026 |
| Registry record updated | December 18, 2025 |
| Trial ID | NCT07004686 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–64 years old, ASA class I–II, scheduled for elective laparoscopic cholecystectomy without regional blocks, and without routine preoperative opioid use or major systemic disease.
✕Probably not a fit
Patients with chronic pain or routine opioid use, significant cardiovascular or neuropsychiatric conditions, pregnancy, extreme BMI, or who cannot attend the Shenzhen site are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults scheduled for elective laparoscopic cholecystectomy under general anesthesia are assigned to analgesia guided by the EEG-derived MGRNOX index or to standard clinical care. In the MGRNOX arm anesthesiologists titrate intraoperative opioid dosing based on the index, while the control arm uses routine signs such as heart rate and blood pressure. Primary outcome measures include intraoperative opioid consumption, with secondary outcomes covering postoperative pain, hemodynamic stability, opioid-related side effects, and recovery metrics. The trial is run at Peking University Shenzhen Hospital and excludes patients with chronic pain, recent opioid use, significant comorbidities, pregnancy, or extreme BMI or age.
Why it matters
Potential benefit: If successful, this approach could lower intraoperative opioid doses and reduce opioid-related side effects and delayed recovery.
How similar studies have gone: Other nociception monitors (e.g., SPI, ANI, qNOX) have shown reduced intraoperative opioid use and improved hemodynamic control in some trials, but MGRNOX itself has not yet been clinically validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old and \< 65 years old; * American Society of Anesthesiologists (ASA) class I-II; * Scheduled to undergo elective laparoscopic cholecystectomy undergeneral anesthesia (without epidural anesthesia, local blocks, or infiltration) Exclusion Criteria: * Pregnancy or lactation period; * BMI ≥35 kg/m² or \<18.5 kg/m²; * Anticipated difficult airway; * Previous diagnosis of hypertension; * History of drug or alcohol abuse within the past 6 months; * Preoperative acute or chronic pain history (routine preoperative use of opioid or non-opioid analgesics), peripheral or central nervous system-related disorders; * Definitively diagnosed psychiatric disorders or other neuropsychiatric conditions severely affecting cognitive judgment, history of psychotropic medication use; * Allergy or intolerance to anesthetic agents; * Baseline mean arterial pressure (MAP) \<60 mmHg or \>120 mmHg; baseline heart rate (HR) \<45 bpm or \>90 bpm (Baseline values defined as first measurement taken in the ward after admission); * History of severe underlying diseases (untreated or ongoing peripheral/central cardiovascular diseases, severe hepatic disorders with elevated bilirubin/INR or hypoalbuminemia, severe renal diseases with elevated creatinine, severe pulmonary diseases potentially causing acute respiratory failure or persistent dyspnea); * Implanted pacemaker, chronic arrhythmia, preoperative use of prescribed anticholinergics, α2-adrenergic agonists, beta-1 adrenergic antagonists, or antiarrhythmic medications.
Where it's running
-
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China Recruiting
Study contacts
- Principal investigator: Tao Luo, MD,PHD — Peking University Shenzhen Hospital
- Study coordinator: Tao Luo, MD,PHD
- Email: luotao_wh@yahoo.com
- Phone: 13510820779
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Serratus vs Erector Spinae Block for Pain After Unilateral Breast Surgery
This trial tests whether serratus posterior superior intercostal plane block or erector spinae plane block reduces chronic pain 3 months after unilateral breast surgery in adult women.
-
Using mHealth to Help Black Adults in the Midwest With Opioid/Stimulant Use and Mood Symptoms
This study tests a mobile health program to support recovery and mood in Black adults who use opioids or stimulants and are seeking treatment.
-
Targeting alcohol-opioid co-use among young adults with a new mobile health tool
A mobile health app is being tested to help young adults reduce drinking and opioid use when they occur together.
-
Dexa vs Dexmedetomidine with Bupivacaine in TAP Block for Laparotomy Analgesia
This study tests whether adding dexamethasone or dexmedetomidine to bupivacaine in a TAP block improves postoperative pain control after laparotomy.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.